|
Market Closed -
Other stock markets
|
Pre-market 20:00:00 | |||
| 104.42 USD | -0.90% |
|
104.30 | -0.12% |
| 07-29 | Deutsche Bank Adjusts CVS Health Price Target to $116 From $92 | MT |
| 07-29 | X, World Federation of Advertisers settle litigation over GARM dispute | RE |
| Market Cap | 133B 116B 108B 99.09B 187B 12,673B 189B 1,272B 497B 6,335B 500B 489B 20,991B | P/E 2026 * |
16.6x | P/E 2027 * | 14.5x |
|---|---|---|---|---|---|
| Enterprise Value | 189B 164B 153B 141B 266B 17,978B 269B 1,804B 705B 8,987B 710B 694B 29,777B | EV / Sales 2026 * |
0.46x | EV / Sales 2027 * | 0.43x |
| Free-Float |
71.2% | Yield 2026 * |
2.55% | Yield 2027 * | 2.63% |
Last Transcript: CVS Health Corporation
| 1 day | -0.90% | ||
| 1 week | -4.50% | ||
| Current month | -0.01% | ||
| 1 month | -0.29% | ||
| 3 months | +27.33% | ||
| 6 months | +38.78% | ||
| Current year | +31.58% |
| 1 week | 103.01 |  | 105.77 |
| 1 month | 101.78 | | 110.68 |
| Current year | 69.51 | | 110.68 |
| 1 year | 62.52 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
Ali Keshavarz
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/14/26 | Free | Director | 1,737 | 0.0001% | ||
| 2/28/26 | Tax | Executive/Senior Manager | 7,886 | 0.0006% | ||
| 2/28/26 | Tax | Chief Executive Officer | 1,944 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -4.50% | +69.93% | +43.26% | 134B | |
| -1.45% | -4.18% | +10.33% | +49.14% | 88.03B | |
| -0.92% | +0.25% | +7.96% | +56.14% | 29.01B | |
| +0.76% | -0.94% | +35.54% | +72.30% | 25.6B | |
| +0.38% | +3.15% | -8.12% | -16.06% | 22.18B | |
| +1.34% | -3.54% | +57.28% | +240.13% | 20.13B | |
| -2.43% | -4.79% | +63.41% | +109.53% | 15B | |
| +1.00% | +0.23% | +3.61% | -1.40% | 14.73B | |
| -7.58% | -5.52% | -4.21% | -12.29% | 13.68B | |
| -1.93% | -4.09% | -14.27% | +92.56% | 11.13B | |
| Average | -1.17% | +0.98% | +22.15% | +63.33% | 37.39B | |
| Weighted average by Cap. | -0.98% | +0.89% | +35.33% | +55.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 409B 356B 332B 305B 576B 38,951B 582B 3,908B 1,528B 19,471B 1,538B 1,504B 64,516B | 427B 370B 345B 317B 600B 40,572B 607B 4,071B 1,591B 20,281B 1,602B 1,567B 67,201B |
| Net income | 8.1B 7.03B 6.56B 6.03B 11.4B 771B 11.52B 77.33B 30.23B 385B 30.42B 29.76B 1,276B | 9.29B 8.07B 7.52B 6.91B 13.07B 884B 13.21B 88.66B 34.66B 442B 34.88B 34.12B 1,464B |
| Net Debt | 55.76B 48.42B 45.15B 41.47B 78.44B 5,304B 79.3B 532B 208B 2,652B 209B 205B 8,786B | 52.15B 45.28B 42.22B 38.78B 73.35B 4,961B 74.16B 498B 195B 2,480B 196B 192B 8,216B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | US$104.42 | -0.90% | 7,225,299 |
| 26-08-03 | US$105.37 | +0.90% | 5,377,252 |
| 26-07-31 | US$104.43 | -0.75% | 7,081,286 |
| 26-07-30 | US$105.22 | -0.66% | 7,738,249 |
| 26-07-29 | US$105.92 | -3.13% | 7,718,243 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
